Search Site

Claire S. Riley, MD

  • Assistant Professor of Neurology
  • Director, Multiple Sclerosis Clinical Care Center
Claire S. Riley, MD

Dr. Claire Riley earned an undergraduate degree from Dartmouth College and a medical degree from Columbia University College of Physicians and Surgeons. She completed an internship in internal medicine and her residency in neurology at Columbia University Medical Center. In addition, she completed a two-year clinical fellowship in the Multiple Sclerosis Clinical Care and Research Center at Columbia University in 2010. Dr. Riley is board certified in neurology by the American Board of Psychiatry and Neurology.

Dr. Riley returned to Columbia University as Director of the Multiple Sclerosis Clinical Care & Research Center in January 2012. She was previously an attending neurologist and assistant professor in the Yale MS Center in New Haven, CT. Dr. Riley regularly teaches medical students, residents and fellows in the MS clinic. She is also an investigator in clinical trials related to multiple sclerosis.

Columbia University's Multiple Sclerosis Clinical Care and Research Center is a premier treatment and research facility for individuals living with multiple sclerosis. Our center remains dedicated to providing the most advanced diagnostic and therapeutic care available to our patients.

Departmental Appointments

  • Department of Neurology
    Division of Multispecialty Neurology

Education & Training

  • Columbia University College of Physicians and Surgeons
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Residency: Harlem Hospital Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

Centers/Institutes/Programs

  • Multiple Sclerosis Clinical Care & Research Center

NIH Grants

  • AN OPEN-LABEL SINGLE ARM STUDY TO EVALUATE THE EFFECTIVENESS AD SAFETY OF OCRELIZUMAB IN PATIENTS WITH EARLY STAGE RELAPSING REMITTING MULTIPLE SCLEROSIS (P&S Industry Clinical Trial)

    Jun 23 2017 - Jun 23 2022

    EFFECT OF MD1003 IN PROGRESSIVE MULTIPLE SCLEROSIS: A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY (P&S Industry Clinical Trial)

    May 31 2017 - May 31 2022

    A MULTICENTER, OPEN-LABEL, 12-MONTH OBSERVATIONAL STUDY EVALUATING THE CLINICAL EFFECTIVENESS AND IMPACT ON PATIENT-REPORTED OUTCOMES OF ORAL TECFIDERA (DIMETHYL FUMARATE) DELAYED-RELEASE CAPS IN PTS WITH RELAPSING FORMS OF MS (P&S Industry Clinical Trial)

    Nov 22 2013 - Nov 22 2018

    SPINAL MUSCULAR ATROPHY (SMA) BIOMARKERS IN THE IMMEDIATE POSTNATAL PERIOD OF DEVELOPMENT NN101 (Federal Gov)

    Sep 30 2011 - Aug 31 2018

    SPINAL MUSCULAR ATROPHY (SMA) BIOMARKERS IN THE IMMEDIATE POSTNATAL PERIOD OF DEVELOPMENT NN101 (Federal Gov)

    Sep 30 2011 - Aug 31 2018

    COLLABORATIVE INTERNATIONAL RESEARCH IN CLINICAL AND LONGITUDINAL EXPERIENCE FOR NEUROMYELITIS OPTICA (NMO) STUDIES (CIRCLES) (Private)

    Apr 1 2016 - Mar 31 2018

    PROTECTION AGAINST COGNITIVE DECLINE IN MS: LONGITUDINAL INVESTIGATION OF RESERVE (Federal Gov)

    Jul 11 2016 - Apr 30 2017

    IMPROVING ACCESS TO MULTIPLE SCLEROSIS SUBSPECIALTY CARE IN WASHINGTON HEIGHTS NEIGHBORHOOD OF MANHATTAN (Private)

    Jan 1 2016 - Dec 31 2016

    BRAIN TEMPERATURE IN MULTIPLE SCLEROSIS: ADVANCING OUR UNDERSTANDING AND TREATMENT OF FATIGUE (Private)

    Oct 1 2015 - Sep 30 2016

    RESERVE AGAINST PHYSICAL DISABILITY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (Private)

    Sep 1 2014 - Aug 31 2015

    IMPROVING ACCESS TO MULTIPLE SCLEROSIS SUBSPECIALTY CARE IN WASHINGTON HEIGHTS NEIGHBORHOOD OF MANHATTAN (Private)

    Jan 1 2014 - Dec 31 2014

    RESTING STATE FUNCTIONAL CONNECTIVITY AS A PREDICT (Private)

    Aug 1 2014 - Nov 30 2014

    A RANDOMIZED CONTROLLED TRIAL OF VITAMIN D SUPPLEMENTATION IN MULTIPLE SCLEROSIS (Private)

    Jul 15 2012 - Mar 31 2014

    IMPROVING ACCESS TO MULTIPLE SCLEROSIS SUBSPECIALTY CARE IN WASHINGTON HEIGHTS NEIGHBORHOOD OF MANHA (Private)

    Jan 1 2013 - Dec 31 2013

    DEVELOPMENT OF A TEST FOR AUTOANTIBODIES IN SUSAC SYNDROME (Private)

    Jan 1 2012 - Dec 31 2013